Tempus AI Inc (NASDAQ: TEM), Chicago, IL – FDA Inspections

Inspection records and compliance data for Tempus AI Inc in Chicago, Illinois. 4 FDA inspections on record, last inspected April 21, 2026. Publicly traded as NASDAQ: TEM.

Company Profile

This profile covers Tempus AI Inc based in Chicago, Illinois, United States.

FDA Inspection History

FDA inspections: 4
OAI: 0
VAI: 0
NAI: 3
Unclassified: 1
Form 483s: 0
Warning letters: 0

First inspected October 29, 2021. Last inspected April 21, 2026.

FDA inspections (4)

Date	Result	FDA center(s)	Insp. #
April 21, 2026	Not classified	Medical Devices & Rad Health	1311772
May 21, 2025	NAI	Medical Devices & Rad Health · Bioresearch Monitoring	1266300
November 21, 2022	NAI	Medical Devices & Rad Health · Compliance: Devices	1193396
October 29, 2021	NAI	Medical Devices & Rad Health · Bioresearch Monitoring	1157368

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Mimosa Acoustics, Inc.

ROHO, Inc

Nancy M. Young, M.D.

Angelo N. Makris, M.D.

Sonoma Orthopedic Products, Inc.

Sonoco TEQ LLC

Bard Brachytherapy, Inc.

Forte Automation Systems Inc

Mishkel, Gregory J.

Mary Martini, MD